Grifols (GRFS) EPS (Basic) Growth (5y) (2015 - 2020)
Grifols (GRFS) EPS (Basic) Growth (5y) (2015 - 2020) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 651.77 Bn | 631.01 Bn | 17.26 Bn |
| 2 | AbbVie | 470.29 Bn | 463.72 Bn | 12.70 Bn |
| 3 | Merck | 374.97 Bn | 367.83 Bn | 12.21 Bn |
| 4 | Novartis Ag | 302.80 Bn | 295.11 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.17 Bn | 252.27 Bn | 12.86 Bn |
| 6 | Amgen | 236.88 Bn | 222.89 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 182.68 Bn | 179.50 Bn | 6.22 Bn |
| 8 | Pfizer | 159.74 Bn | 148.04 Bn | 10.94 Bn |
| 9 | Gsk | 106.06 Bn | 101.89 Bn | 8.24 Bn |
| 10 | Grifols | 5.46 Bn | 4.46 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2020 | 17.86% |
| Dec 31, 2019 | 4.76% |
| Mar 31, 2019 | 3.17% |
| Dec 31, 2018 | 11.15% |
| Jun 30, 2018 | 16.84% |
| Mar 31, 2018 | 17.10% |
| Dec 31, 2017 | 21.57% |
| Jun 30, 2017 | 22.10% |
| Mar 31, 2017 | 20.34% |
| Dec 31, 2016 | 74.38% |
| Sep 30, 2016 | 28.12% |
| Jun 30, 2016 | 56.64% |
| Mar 31, 2016 | 44.40% |
| Dec 31, 2015 | 33.97% |
| Sep 30, 2015 | 24.06% |